This can happen during illness, missed insulin, severe insulin deficiency, or prolonged lack of food
Reduced Risk of Cardiovascular Disease: By promoting weight loss and improving metabolic markers, these treatments can lower the risk of heart disease and stroke
Current evidence from large-scale studies is reassuring, showing no increased breast cancer risk associated with GLP-1 use
Across Europe there are labour shortages
Safety depends on your overall health, medications and adherence to professional protocols
Schedule prompt medical evaluation (within 24-48 hours) for: Gradually worsening shortness of breath over days to weeks Dyspnea with exertion that is new or significantly worse than baseline Breathing difficulty accompanied by persistent cough or fever Leg swelling, weight gain, or orthopnea (difficulty breathing when lying flat) Respiratory symptoms associated with severe ongoing nausea, vomiting, or inability to maintain hydration Patients should not discontinue GLP-1 medications without medical guidance (except in cases of suspected severe allergic reactions), but should contact their healthcare provider promptly to discuss respiratory symptoms